🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re headed to Poland next week for @MicroTAS2023 where we’ll be presenting details on how our platform leverages microfluidics to enable single cell precision at scale for unprecedented consistency in molecular payload delivery. #nanotechnology #innovation #microfluidics

It was great to tour Bayer AG’s new #celltherapy manufacturing facility in Berkeley last week & have the opportunity to engage w/ scientists in the cell & #genetherapy community about the emerging technologies that will help usher in a brighter future for patients. Biocom California

Congrats to the #SickleCell community on the FDA approval of Casgevy - the 1st CRISPR therapy for people w/ severe disease. Today’s news is a great reminder of the importance of our work, which aims to create a future where personalized medicine is accessible to all👏

For those who missed this year’s Alliance for Regenerative Medicine (ARM) #MeetingOnTheMesa, be sure to check out our CEO, Anil Narasimha’s, talk on ex-vivo nanoneedle-based delivery of #macromolecules into cells! youtube.com/watch?v=vBYUW5…

Happy Holidays to all from Mekonos! Wishing our incredible community a season filled with joy, warmth, and unforgettable moments. Thank you for being a part of our journey!

We’re thrilled to share a preview of our progress to bring something BIG to the #CellandGeneTherapy space – an innovative approach that will soon redefine the way these therapies are developed & manufactured. 🧪🧬 Get in touch at #JMP24 vimeo.com/900200446?shar…

We’re energized by the conversations we’re having here at #JPM24 which only strengthen our resolve to build a future where personalized medicine is accessible to all. Want to learn more? Get in touch or visit our website: mekonos.com

We’re headed to Miami to join an amazing group of drug developers, investors & solution providers at #AdvancedTherapiesWeek. We'd love to meet – get in touch at mekonos.com/contact. #CellandGeneTherapy #CGT #biomanufacturing

#CellandGeneTherapy manufacturers: brace yourselves for a game-changer! Take a peek at our progress to redefine high efficiency, high viability #cellengineering like you’ve never seen before! #ExVivoDelivery #SystemOnaChip vimeo.com/900200446

We’re gearing up for #BiocomGPIC where we’ll join biotech leaders to discuss the latest trends in investment & partnering activities. Interested in a 1-1 discussion? We’d love to hear from you. Get in touch via the partnering platform! biocom.org/conferences/gl…

Meet our disruptor! Co-Founder/CEO, Anil Narasimha, sat down with Authority Magazine to discuss how Mekonos is shaking up the world of #exvivo #cellular delivery to make #cellandgenetherapy more accessible. medium.com/authority-maga…

On Thurs. 4/11 Mekonos will be presenting at #CGMed24! Attending? Join us at 9:30am (GMT+2) to learn more about how Mekonos’ cutting-edge platform combines three powerful technologies to unlock new abilities in #cellengineering.

We were thrilled to celebrate with the hardworking #CGT community at #CGMed24 last night with a pizza feast to help fuel everyone for a productive few days of panel discussions, company presentations, workshops & partnering meetings. A big thank you to all who joined us!

Curious to learn how our scalable platform offers the delivery of any molecular cargo to any cell, supporting #cellandgene therapy programs from the R&D stage through the #manufacturing process? Check out this video and get in touch at #CGMed24! vimeo.com/905773839

The potential of our platform would not be possible w/o the dedicated efforts of the countless scientists before us in #GenomicResearch. In their honor on #NationalDNADay, we’re excited to share a look at how our technology is redefining #cellengineering. vimeo.com/905773839

Join us at SynBioBeta 2024 for a panel discussion on the latest advancements in #genetech for therapeutic use & the potential impact that new #cellengineering approaches will have on the healthcare field. #SynBioBeta2024 #SyntheticBiology

We’re looking forward to exploring emerging #InnateImmunity #CancerImmunotherapy research with other field leaders Keystone Symposia Myeloid Targeting Strategies for Cancer Treatment in Killarney! Attending? Get in touch! #KSMyeloidTargets24

We hope you will join us next week at #SynBioBeta2024, for an in-depth panel discussion on “Advancing Drug Discovery & Screening” that will explore the latest strategies & technologies revolutionizing #drugdiscovery & screening processes. See you in San Jose!

Twitter: We’re excited to announce that we’re partnering with Accelerated Biosciences to codevelop a powerful, new manufacturing cell line based on their human Trophoblast #StemCells (hTSCs) & #Gene Engineered Multi-Sites (GEMS) technology! mekonos.com/news-posts/mek…

We’re enroute to Baltimore for #ASGCT2024 where we’ll be presenting a poster on Silicon Nanoneedle Microarray-Based Delivery of #CellandGeneTherapies. Stop by the Nonviral Therapeutic Gene Delivery and Synthetic/Molecular Conjugates poster session on Thursday to say hi!